Linking aberrant glycosylation of plasma glycoproteins with progression of myelodysplastic syndromes: a study based on plasmonic biosensor and lectin array

por Chrastinová, Leona, Pastva, Ondřej, Bocková, Markéta, Kovářová, Hana, Ceznerová, Eliška, Kotlín, Roman, Pecherková, Pavla, Štikarová, Jana, Hlaváčková, Alžběta, Havlíček, Marek, Válka, Jan, Homola, Jiří, Suttnar, Jiří
Publicado 2023

TP53 mutation variant allele frequency is a potential predictor for clinical outcome of patients with lower-risk myelodysplastic syndromes

por Belickova, Monika, Vesela, Jitka, Jonasova, Anna, Pejsova, Barbora, Votavova, Hana, Merkerova, Michaela Dostalova, Zemanova, Zuzana, Brezinova, Jana, Mikulenkova, Dana, Lauermannova, Marie, Valka, Jan, Michalova, Kyra, Neuwirtova, Radana, Cermak, Jaroslav
Publicado 2016

Circulating Small Noncoding RNAs Have Specific Expression Patterns in Plasma and Extracellular Vesicles in Myelodysplastic Syndromes and Are Predictive of Patient Outcome

por Hrustincova, Andrea, Krejcik, Zdenek, Kundrat, David, Szikszai, Katarina, Belickova, Monika, Pecherkova, Pavla, Klema, Jiri, Vesela, Jitka, Hruba, Monika, Cermak, Jaroslav, Hrdinova, Tereza, Krijt, Matyas, Valka, Jan, Jonasova, Anna, Dostalova Merkerova, Michaela
Publicado 2020